2024 | 2023 | ||||||
| Adjusting items | Adjusting items | ||||||
| Adjusted | (note 2) | Total | Adjusted | (note 2) | Total | ||
| £m | £m | £m | £m | £m | £m | ||
Revenue | 1 | ||||||
Cost of sales | ( | ( | ( | ( | |||
Gross profit | |||||||
Other operating income | |||||||
Research and development | 3 | ( | ( | ( | ( | ( | |
Selling and marketing | ( | ( | ( | ( | |||
Administration and shared services | ( | ( | ( | ( | ( | ( | |
Foreign exchange gain/(loss) | ( | ||||||
Operating profit | ( | ( | |||||
Financial income | 6 | ||||||
Financial expenditure | 7 | ( | ( | ( | ( | ( | |
Profit/(loss) before income tax | 1 | ( | ( | ||||
Income tax (expense)/credit | 8 | ( | ( | ( | ( | ( | |
Profit/(loss) for the year attributable to equity shareholders of the parent | ( | ( | |||||
Earnings per share | pence | pence | pence | pence | |||
Basic earnings per share | 10 | ||||||
Fromprofitfortheyear | |||||||
Diluted earnings per share | 10 | ||||||
Fromprofitfortheyear |
| 2024 | 2023 | ||
| £m | £m | ||
Profit for the year | |||
| Other comprehensive (expense)/income: | |||
| Items that may be reclassified subsequently to Consolidated Statement of Income | |||
Foreign exchange translation differences | ( | ||
| Items that will not be reclassified to Consolidated Statement of Income | |||
| Remeasurement loss in respect of post-retirement benefits | 24 | ( | ( |
Tax credit on items that will not be reclassified to Consolidated Statement of Income | |||
Total other comprehensive expense | ( | ( | |
Total comprehensive income for the year attributable to equity shareholders of the parent |
| 2024 | 2023 | ||
| £m | £m | ||
| Assets | |||
| Non-current assets | |||
Property, plant and equipment | 12 | ||
Intangible assets | 13 | ||
Right-of-use assets | 14 | ||
Long-term receivables | |||
Derivative financial instruments | 22 | ||
Retirement benefit asset | 24 | ||
Deferred tax assets | 8 | ||
| Current assets | |||
Inventories | 15 | ||
Trade and other receivables | 16 | ||
Current income tax receivable | |||
Derivative financial instruments | 22 | ||
Cash and cash equivalents | 18 | ||
Total assets | |||
| Equity | |||
| Capital and reserves attributable to the company’s equity shareholders | |||
Share capital | 25 | ||
Share premium | |||
Other reserves | |||
Translation reserve | |||
Retained earnings | |||
| Liabilities | |||
| Non-current liabilities | |||
Bank loans | 19 | ||
Lease payables | 14 | ||
Deferred tax liabilities | 8 | ||
| Current liabilities | |||
Bank loans and overdrafts | 19 | ||
Trade and other payables | 20 | ||
Lease payables | 14 | ||
Current income tax payables | |||
Derivative financial instruments | 22 | ||
Provisions | 21 | ||
Total liabilities | |||
Total liabilities and equity |
| Share | Share | Other | Translation | Retained | ||
| capital | premium | reserves | reserve | earnings | Total | |
| £m | £m | £m | £m | £m | £m | |
As at 1 April 2023 | ||||||
Profit for the year | ||||||
Foreign exchange translation differences | ( | ( | ||||
Remeasurement loss in respect of post-retirement benefits | ( | ( | ||||
| Tax credit on items that will not be reclassified | ||||||
to Consolidated Statement of Income | ||||||
Total comprehensive (expense)/income | ( | |||||
Share-based payment transactions | ||||||
Income tax on share-based payment transactions | ( | ( | ||||
Proceeds from shares issued | ||||||
Dividends | ( | ( | ||||
Total transactions with owners: | ( | ( | ||||
As at 31 March 2024 | ||||||
As at 1 April 2022 | ||||||
Profit for the year | ||||||
Foreign exchange translation differences | ||||||
Remeasurement loss in respect of post-retirement benefits | ( | ( | ||||
| Tax credit on items that will not be reclassified | ||||||
to Consolidated Statement of Income | ||||||
Total comprehensive income | ||||||
Share-based payment transactions | ||||||
Income tax on share-based payment transactions | ||||||
Proceeds from shares issued | ||||||
Dividends | ( | ( | ||||
Total transactions with owners: | ( | ( | ||||
As at 31 March 2023 |
| 2024 | 2023 | ||
| £m | £m | ||
| Cash flows from operating activities | |||
Profit for the year | |||
| Adjustments for: | |||
Income tax expense | 8 | ||
Net financial income | ( | ( | |
Fair value movement on financial derivatives | ( | ||
WITec post-acquisition gross margin adjustment | |||
Impairment of capitalised development costs | 13 | ||
Amortisation of right-of-use assets | 14 | ||
Depreciation of property, plant and equipment | 12 | ||
Amortisation of intangible assets | 13 | ||
Charge in respect of equity settled employee share schemes | 26 | ||
Contributions paid to the pension scheme more than the charge to operating profit | ( | ( | |
Increase in inventories | 27 | ( | ( |
Increase in receivables | 27 | ( | ( |
(Decrease)/increase in payables and provisions | 27 | ( | |
Increase in customer deposits | 27 | ||
Cash generated from operations | |||
Interest paid | ( | ( | |
Income taxes paid | ( | ( | |
Net cash from operating activities | |||
| Cash flows from investing activities | |||
Proceeds from sale of property, plant and equipment | |||
Acquisition of property, plant and equipment | ( | ( | |
Acquisition of subsidiaries, net of cash acquired | 11 | ( | ( |
Capitalised development expenditure | ( | ( | |
Interest received | |||
Net cash used in investing activities | ( | ( | |
| Cash flows from financing activities | |||
Proceeds from issue of share capital | |||
Interest paid on lease liabilities | 14 | ( | ( |
Payment of capital element of leases | 14 | ( | ( |
Repayment of borrowings | ( | ( | |
Dividends paid | ( | ( | |
Net cash used in financing activities | ( | ( | |
Change in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of the year | |||
Effect of exchange rate fluctuations on cash held | ( | ||
Cash and cash equivalents at end of the year | 18 | ||
| Comprised of: | |||
Cash and cash equivalents as per the Consolidated Statement of Financial Position | 18 | ||
Bank overdrafts | 23 | ( | ( |
| year’s exposure, any gains or losses resulting from the |
| change in fair value are recognised as an adjusting item |
| in operating expenses. |
| The fair value of forward exchange contracts is their market |
| price at the Consolidated Statement of Financial Position |
| Freehold buildings, long | 50 years |
| leasehold land and buildings | |
Furniture and fittings | 10 years |
Machinery and other equipment | 5 to 10 years |
Computer equipment | 4 years |
Vehicles | 4 years |
Capitalised development costs | 3 to 5 years |
Technology-related acquired intangibles | 5 to 14 years |
| Customer-related acquired intangibles | 6 months |
| to 15 years | |
Development costs acquired intangibles | 10 years |
Software | 10 years |
| Materials & | Research & | Service & | ||
| Characterisation | Discovery | Healthcare | Total | |
| 2024 | £m | £m | £m | £m |
Total segment revenue | 252.2 | 142.1 | 76.1 | 470.4 |
Segment adjusted operating profit | 46.4 | 13.6 | 20.3 | 80.3 |
| Materials & | Research & | Service & | ||
| Characterisation | Discovery | Healthcare | Total | |
| 2023 | £m | £m | £m | £m |
Total segment revenue | 234.5 | 139.4 | 70.8 | 444.7 |
Segment adjusted operating profit | 40.5 | 18.0 | 22.0 | 80.5 |
| Materials & | Research & | Service & | Unallocated | ||
| Characterisation | Discovery | Healthcare | Group items | Total | |
| 2024 | £m | £m | £m | £m | £m |
Segment adjusted operating profit | 46.4 | 13.6 | 20.3 | – | 80.3 |
Intellectual property litigation settlement | – | 3.3 | – | – | 3.3 |
Adjustments relating to defined benefit pension schemes | – | – | – | (0.4) | (0.4) |
Transaction-related costs | – | (1.0) | – | – | (1.0) |
Restructuring costs and charges associated with management changes | (1.7) | – | – | (2.0) | (3.7) |
Intellectual property litigation costs | – | (0.4) | – | – | (0.4) |
Amortisation and impairment of acquired intangibles | (3.0) | (6.1) | – | – | (9.1) |
Fair value movement on financial derivatives | – | – | – | (0.7) | (0.7) |
Financial income | – | – | – | 4.7 | 4.7 |
Financial expenditure | – | – | – | (1.7) | (1.7) |
Profit/(loss) before income tax | 41.7 | 9.4 | 20.3 | (0.1) | 71.3 |
| Materials & | Research & | Service & | Unallocated | ||
| Characterisation | Discovery | Healthcare | Group items | Total | |
| 2023 | £m | £m | £m | £m | £m |
Segment adjusted operating profit | 40.5 | 18.0 | 22.0 | – | 80.5 |
Restructuring costs | (0.4) | – | – | – | (0.4) |
Release of provision on disposal | – | – | 0.4 | – | 0.4 |
Intellectual property litigation | – | (0.5) | – | – | (0.5) |
Impairment of capitalised development costs | (0.8) | – | – | – | (0.8) |
WITec post-acquisition gross margin adjustment | (0.5) | – | – | – | (0.5) |
Amortisation and impairment of acquired intangibles | (3.1) | (6.2) | – | – | (9.3) |
Fair value movement on financial derivatives | – | – | – | 3.0 | 3.0 |
Financial income | – | – | – | 2.7 | 2.7 |
Financial expenditure | – | – | – | (1.6) | (1.6) |
Profit before income tax | 35.7 | 11.3 | 22.4 | 4.1 | 73.5 |
| Materials & | Research & | Service & | Unallocated | ||
| Characterisation | Discovery | Healthcare | Group items | Total | |
| £m | £m | £m | £m | £m | |
Capital expenditure | (18.0) | (6.6) | (0.1) | (2.3) | (27.0) |
Depreciation of property, plant and equipment | (3.3) | (1.5) | – | (0.5) | (5.3) |
Amortisation of right-of-use assets | (2.4) | (0.4) | – | (2.2) | (5.0) |
Amortisation and impairment of acquired intangibles | (3.5) | (6.3) | – | – | (9.8) |
Capitalised development expenditure | (0.1) | (0.6) | – | – | (0.7) |
| 2024 | 2023 | |
| £m | £m | |
UK | 30.4 | 29.4 |
China | 127. 4 | 107.4 |
Japan | 43.5 | 46.7 |
USA | 111.6 | 121.2 |
Germany | 35.5 | 32.1 |
Rest of Europe | 50.3 | 43.4 |
Rest of Asia | 50.6 | 47.1 |
Rest of World | 21.1 | 17.4 |
470.4 | 444.7 |
| 2024 | 2023 | |
| Non-current assets (excluding deferred tax) | £m | £m |
UK | 191.0 | 189.6 |
Germany | 32.1 | 34.8 |
USA | 12.5 | 13.9 |
Japan | 6.2 | 1.9 |
China | 4.0 | 2.9 |
Rest of Europe | 22.1 | 6.5 |
Rest of Asia | 0.2 | 0.2 |
Rest of World | 0.3 | 0.3 |
268.4 | 250.1 |
2024 | 2023 | |||
| Operating | Profit before | Operating | Profit before | |
| profit | income tax | profit | income tax | |
| £m | £m | £m | £m | |
Statutory measure | 68.3 | 71.3 | 72.4 | 73.5 |
Intellectual property litigation settlement | (3.3) | (3.3) | – | – |
Release of provision on disposal | – | – | (0.4) | (0.4) |
Adjustments relating to defined benefit pension schemes | 0.4 | 0.4 | – | – |
Transaction-related costs | 1.0 | 1.0 | – | – |
WITec post-acquisition gross margin adjustment | – | – | 0.5 | 0.5 |
Restructuring costs and charges associated with management changes | 3.7 | 3.7 | 0.4 | 0.4 |
Intellectual property litigation costs | 0.4 | 0.4 | 0.5 | 0.5 |
Impairment of capitalised development costs | – | – | 0.8 | 0.8 |
Amortisation and impairment of acquired intangibles | 9.1 | 9.1 | 9.3 | 9.3 |
Fair value movement on financial derivatives | 0.7 | 0.7 | (3.0) | (3.0) |
Unwind of discount in respect of contingent consideration | – | – | – | 0.4 |
Total adjusting items | 12.0 | 12.0 | 8.1 | 8.5 |
Adjusted measure | 80.3 | 83.3 | 80.5 | 82.0 |
Adjusted income tax expense | (20.3) | (17.0) | ||
Adjusted profit | 80.3 | 63.0 | 80.5 | 65.0 |
Adjusted effective tax rates | 24.4% | 20.7% |
| 2024 | 2023 | |
| £m | £m | |
Net (decrease)/increase in cash and cash equivalents | (13.1) | 13.5 |
Effect of exchange rate fluctuations on cash held | (2.9) | 0.3 |
Movement in net cash in the year | (16.0) | 13.8 |
Bank loans at First Light Imaging acquired | (2.2) | – |
Repayment of borrowings | 1.8 | 0.5 |
Net cash after borrowings at the start of the year | 100.2 | 85.9 |
Net cash after borrowings at the end of the year | 83.8 | 100.2 |
| 2024 | 2023 | |
| £m | £m | |
Bank loans at First Light Imaging | (0.8) | – |
Covid-19 loan at WiTec | (0.9) | (1.3) |
Overdrafts | (12.3) | (11.2) |
Cash and cash equivalents | 97. 8 | 112.7 |
Net cash after borrowings at the end of the year | 83.8 | 100.2 |
| Materials & | Research & | ||
| Characterisation | Discovery | Total | |
| 2024 | £m | £m | £m |
R&D expense charged to the Consolidated Statement of Income | 28.0 | 11.1 | 39.1 |
Less: depreciation of R&D-related fixed assets | – | (0.2) | (0.2) |
Add: amounts capitalised as fixed assets | 0.2 | – | 0.2 |
| Less: amortisation and impairment of R&D costs | |||
previously capitalised as intangibles | (0.5) | (0.1) | (0.6) |
Add: amounts capitalised as intangible assets | 0.1 | 0.6 | 0.7 |
Total cash spent on R&D during the year | 27.8 | 11.4 | 39.2 |
| Materials & | Research & | ||
| Characterisation | Discovery | Total | |
| 2023 | £m | £m | £m |
R&D expense charged to the Consolidated Statement of Income | 26.5 | 10.2 | 36.7 |
Less: depreciation of R&D-related fixed assets | – | (0.3) | (0.3) |
Add: amounts capitalised as fixed assets | – | – | – |
Less: amortisation of R&D costs previously capitalised as intangibles | (2.1) | (0.1) | (2.2) |
Add: amounts capitalised as intangible assets | 0.4 | 0.2 | 0.6 |
Total cash spent on R&D during the year | 24.8 | 10.0 | 34.8 |
| 2024 | 2023 | |
| £m | £m | |
Wages and salaries | 131.5 | 121.9 |
Social security costs | 15.5 | 17.1 |
Contributions to defined contribution plans (Note 24) | 6.4 | 6.1 |
Defined benefit income (Note 24) | (1.0) | (1.1) |
Charge in respect of employee share options | 3.0 | 2.4 |
155.4 | 146.4 |
| 2024 | 2023 | |
| Number | Number | |
Production | 894 | 796 |
Sales and Marketing | 555 | 495 |
Research and Development | 487 | 456 |
Administration and Shared Services | 308 | 280 |
2,244 | 2,027 |
| 2024 | 2023 | |
| £’000 | £’000 | |
Audit of these Financial Statements | 345 | 250 |
| Amounts received by the auditor and its associates in respect of: | ||
– Audit of Financial Statement of subsidiaries pursuant to legislation | 757 | 542 |
– Audit-related assurance services | 50 | 47 |
– Other assurance services | 8 | 8 |
Total fees payable to the auditor and its associates | 1,160 | 847 |
| 2024 | 2023 | |
| £m | £m | |
Interest receivable | 3.2 | 1.1 |
Interest credit on pension scheme net assets | 1.5 | 1.6 |
4.7 | 2.7 |
| 2024 | 2023 | |
| £m | £m | |
Bank interest payable | 0.9 | 0.7 |
Interest on lease liabilities | 0.8 | 0.5 |
Unwind of discount on contingent consideration | – | 0.4 |
1.7 | 1.6 |
| 2024 | 2023 | |
| £m | £m | |
| Recognised in the Consolidated Statement of Income | ||
| Current tax expense | ||
Current year | 17.1 | 10.2 |
Adjustment in respect of prior years | 1.1 | 0.3 |
18.2 | 10.5 | |
| Deferred tax expense | ||
Origination and reversal of temporary differences | 1.6 | 5.1 |
Adjustment in respect of prior years | 0.8 | (0.7) |
2.4 | 4.4 | |
Total tax expense | 20.6 | 14.9 |
| Reconciliation of effective tax rate | ||
Profit before income tax | 71.3 | 73.5 |
Income tax using the weighted average statutory tax rate of 25% (2023: 21%) | 17.8 | 15.4 |
| Effect of: | ||
Tax rates other than the weighted average statutory rate | (0.2) | 0.3 |
Change in rate at which deferred tax recognised | – | 1.0 |
Transaction costs, deferred consideration and impairments not deductible for tax | 0.4 | – |
Non-taxable income and expenses | 0.7 | (1.4) |
Adjustment in respect of prior years | 1.9 | (0.4) |
Total tax expense | 20.6 | 14.9 |
| Taxation credit recognised directly in other comprehensive income | ||
Current tax – relating to employee benefits | (2.1) | – |
Deferred tax – relating to employee benefits | (2.7) | (9.7) |
| Taxation (credit)/charge recognised directly in equity | ||
Current tax – relating to share options | (0.6) | – |
Deferred tax – relating to share options | 1.1 | (0.7) |
| Property, | |||||||
| plant and | Employee | Intangible | |||||
| equipment | Inventory | benefits | assets | Tax losses | Other | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Balance at 1 April 2022 | (0.9) | 3.2 | ( 7. 8) | (7.0) | 6.7 | 4.1 | (1.7) |
Recognised in income | (3.1) | 0.4 | (2.5) | 2.0 | (1.5) | 0.3 | (4.4) |
Recognised in other comprehensive income | – | – | 9.7 | – | – | – | 9.7 |
Recognised directly in equity | – | – | 0.7 | – | – | – | 0.7 |
Effect of movements in foreign exchange rates | – | 0.1 | – | – | 0.3 | – | 0.4 |
Balance at 31 March 2023 | (4.0) | 3.7 | 0.1 | (5.0) | 5.5 | 4.4 | 4.7 |
Recognised in income | (3.4) | 0.7 | 1.0 | 1.4 | (2.1) | – | (2.4) |
Recognised in other comprehensive income | – | – | 2.7 | – | – | – | 2.7 |
Recognised directly in equity | – | – | (1.1) | – | – | – | (1.1) |
Acquired on business combination | – | – | – | (2.5) | – | – | (2.5) |
Effect of movements in foreign exchange rates | (0.1) | (0.1) | (0.3) | – | – | (0.1) | (0.6) |
Balance at 31 March 2024 | (7.5) | 4.3 | 2.4 | (6.1) | 3.4 | 4.3 | 0.8 |
Assets | Liabilities | Net | ||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
| £m | £m | £m | £m | £m | £m | |
Gross assets/(liabilities) | 15.6 | 15.6 | (14.8) | (10.9) | 0.8 | 4.7 |
Offset | (1.9) | (3.1) | 1.9 | 3.1 | – | – |
Net assets/(liabilities) | 13.7 | 12.5 | (12.9) | (7.8) | 0.8 | 4.7 |
| 2024 | 2023 | |
| £m | £m | |
Tax losses | 0.5 | 0.3 |
| 2024 | 2023 | |
| pence | pence | |
Previous period final dividend | 14.9 | 13.7 |
Current period interim dividend | 4.9 | 4.6 |
19.8 | 18.3 |
| 2024 | 2023 | |
| pence | pence | |
Interim dividend | 4.9 | 4.6 |
Final dividend | 15.9 | 14.9 |
| 2024 | 2023 | |
| Shares million | Shares million | |
Weighted average number of shares outstanding | 57.9 | 57.7 |
Less: weighted average number of shares held by Employee Benefit Trust | (0.1) | – |
Weighted average number of shares used in calculation of basic earnings per share | 57. 8 | 57.7 |
Effect of shares under option | 0.8 | 0.7 |
Number of ordinary shares per diluted earnings per share calculations | 58.6 | 58.4 |
2024 | 2023 | |||
£m | Pence | £m | Pence | |
Profit attributable to equity shareholders of the parent/Basic EPS | 50.7 | 87.7 | 58.6 | 101.6 |
Total underlying adjustments to profit before tax (Note 2) | 12.0 | 20.8 | 8.5 | 14.7 |
Related tax effects | 0.3 | 0.5 | (2.1) | (3.6) |
| Adjusted profit attributable to equity shareholders | ||||
of the parent/adjusted EPS | 63.0 | 109.0 | 65.0 | 112.7 |
Diluted basic EPS | 86.5 | 100.3 | ||
Diluted adjusted EPS | 107. 5 | 111.3 |
| Provisional | Provisional fair | ||
| Book value | adjustments | value | |
| £m | £m | £m | |
Intangible assets | 0.1 | 10.3 | 10.4 |
Property, plant and equipment | 0.5 | – | 0.5 |
Right-of-use assets | 0.7 | – | 0.7 |
Inventories | 1.7 | – | 1.7 |
Trade and other receivables | 2.9 | – | 2.9 |
Deferred tax | – | (2.6) | (2.6) |
Trade and other payables | (2.1) | – | (2.1) |
Lease liabilities | (0.7) | – | (0.7) |
Bank loans | (2.2) | – | (2.2) |
Cash | 0.6 | – | 0.6 |
Net assets acquired | 1.5 | 7.7 | 9.2 |
Goodwill | 5.4 | ||
Total consideration | 14.6 | ||
Net debt acquired | 1.6 | ||
Deferred consideration after discounting to transaction date | (2.8) | ||
Net cash outflow relating to the acquisition | 13.4 |
| Land and | Plant and | Fixtures and | ||
| buildings | equipment | fittings | Total | |
| £m | £m | £m | £m | |
| Cost | ||||
Balance at 1 April 2022 | 21.8 | 40.4 | 8.3 | 70.5 |
Additions | 24.2 | 6.0 | 2.1 | 32.3 |
Disposals | (0.1) | (3.7) | (0.3) | (4.1) |
Exchange differences | – | 0.4 | 0.1 | 0.5 |
Balance at 31 March 2023 and 1 April 2023 | 45.9 | 43.1 | 10.2 | 99.2 |
Additions – business combinations | 0.1 | 0.3 | 0.1 | 0.5 |
Additions | 15.8 | 9.7 | 1.5 | 27.0 |
Disposals | (0.6) | (0.5) | (0.1) | (1.2) |
Exchange differences | 0.3 | 0.4 | (0.2) | 0.5 |
Balance at 31 March 2024 | 61.5 | 53.0 | 11.5 | 126.0 |
| Depreciation and impairment losses | ||||
Balance at 1 April 2022 | 5.5 | 27.4 | 5.9 | 38.8 |
Depreciation charge for the year | 0.4 | 4.0 | 0.4 | 4.8 |
Disposals | – | (3.7) | (0.3) | (4.0) |
Exchange differences | – | 0.3 | – | 0.3 |
Balance at 31 March 2023 and 1 April 2023 | 5.9 | 28.0 | 6.0 | 39.9 |
Depreciation charge for the year | 0.5 | 4.2 | 0.6 | 5.3 |
Disposals | (0.5) | (0.5) | (0.1) | (1.1) |
Exchange differences | – | 1.4 | – | 1.4 |
Balance at 31 March 2024 | 5.9 | 33.1 | 6.5 | 45.5 |
| Carrying amounts | ||||
Balance at 1 April 2022 | 16.3 | 13.0 | 2.4 | 31.7 |
Balance at 31 March 2023 and 1 April 2023 | 40.0 | 15.1 | 4.2 | 59.3 |
Balance at 31 March 2024 | 55.6 | 19.9 | 5.0 | 80.5 |
| Customer- | Technology- | Development | Development | ||||
| related | related | costs | costs | ||||
| acquired | acquired | acquired | internally | ||||
| Goodwill | intangibles | intangibles | intangibles | generated | Software | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
| Cost | |||||||
Balance at 1 April 2022 | 122.6 | 33.1 | 98.2 | 1.8 | 49.2 | 4.3 | 309.2 |
Additions – internally generated | – | – | – | – | 0.6 | – | 0.6 |
Disposals | – | – | – | – | (12.5) | – | (12.5) |
| Effect of movements in foreign | |||||||
exchange rates | 2.0 | 1.0 | 2.8 | – | – | – | 5.8 |
| Balance at 31 March 2023 | |||||||
and 1 April 2023 | 124.6 | 34.1 | 101.0 | 1.8 | 37. 3 | 4.3 | 303.1 |
Additions – business combinations | 5.4 | 0.2 | 10.1 | – | – | 0.1 | 15.8 |
Additions – internally generated | – | – | – | – | 0.7 | 0.2 | 0.9 |
Disposals | – | – | – | – | (2.8) | – | (2.8) |
| Effect of movements in foreign | |||||||
exchange rates | (0.8) | (0.4) | (1.3) | – | – | – | (2.5) |
Balance at 31 March 2024 | 129.2 | 33.9 | 109.8 | 1.8 | 35.2 | 4.6 | 314.5 |
| Amortisation and impairment losses | |||||||
Balance at 1 April 2022 | 22.2 | 24.8 | 71.9 | 1.5 | 45.2 | 2.9 | 168.5 |
Amortisation and impairment charged | – | 1.4 | 7.8 | 0.1 | 2.2 | – | 11.5 |
Disposals – other Effect of movements in foreign | – | – | – | – | (12.5) | – | (12.5) |
exchange rates | 0.7 | 0.8 | 1.9 | – | – | 0.1 | 3.5 |
| Balance at 31 March 2023 | |||||||
and 1 April 2023 | 22.9 | 27.0 | 81.6 | 1.6 | 34.9 | 3.0 | 171.0 |
Amortisation and impairment charged | – | 1.2 | 7.9 | – | 0.6 | 0.1 | 9.8 |
Disposals | – | – | – | – | (2.8) | – | (2.8) |
| Effect of movements in foreign | |||||||
exchange rates | (0.3) | (0.4) | (0.6) | (0.3) | 0.1 | 0.1 | (1.4) |
Balance at 31 March 2024 | 22.6 | 27.8 | 88.9 | 1.3 | 32.8 | 3.2 | 176.6 |
| Carrying amounts | |||||||
Balance at 1 April 2022 | 100.4 | 8.3 | 26.3 | 0.3 | 4.0 | 1.4 | 140.7 |
| Balance at 31 March 2023 | |||||||
and 1 April 2023 | 101.7 | 7.1 | 19.4 | 0.2 | 2.4 | 1.3 | 132.1 |
Balance at 31 March 2024 | 106.6 | 6.1 | 20.9 | 0.5 | 2.4 | 1.4 | 137.9 |
2024 | 2023 | |||
| Remaining | ||||
| Amortisation | amortisation | |||
| £m | period years | period years | £m | |
Trademarks – Andor | 3.9 | 15.0 | 4.8 | 4.7 |
| Technology, know–how and patents – Andor: | ||||
– Product related | 7.3 | 12.0 | 1.8 | 11.9 |
– Software related | – | 10.0 | – | 0.9 |
Trademarks – WITec | 2.0 | 10.0 | 7.6 | 2.3 |
Technology, know–how and patents – WITec | 2.4 | 5.0 | 2.6 | 3.6 |
Trademarks – First Light Imaging | 0.2 | 2.0 | 1.8 | – |
| Technology, know–how and patents – First Light Imaging: | ||||
– OCAM | 0.3 | 12.0 | 11.8 | – |
– C-RED | 9.3 | 14.0 | 13.8 | – |
Technology, know–how and patents – Asylum | 1.0 | 12.0 | 0.7 | 2.4 |
| 2024 | 2023 | |
| £m | £m | |
| Materials & Characterisation | ||
NanoAnalysis | 9.9 | 10.0 |
Magnetic Resonance | 2.3 | 2.3 |
WITec | 21.0 | 21.5 |
| Research & Discovery | ||
Andor | 66.7 | 61.2 |
NanoScience | 6.7 | 6.7 |
106.6 | 101.7 |
| Property leases | Other leases | Total | |
| £m | £m | £m | |
| Cost | |||
Balance at 1 April 2022 | 25.0 | 2.6 | 27.6 |
Additions | 17.4 | 0.8 | 18.2 |
Modifications | (1.0) | – | (1.0) |
Disposals | – | (0.5) | (0.5) |
Exchange differences | 1.1 | 0.1 | 1.2 |
Balance at 31 March 2023 | 42.5 | 3.0 | 45.5 |
Additions – business combinations | 0.7 | – | 0.7 |
Additions | 5.8 | 0.2 | 6.0 |
Disposals | (1.1) | (0.2) | (1.3) |
Exchange differences | (1.5) | (0.1) | (1.6) |
Balance at 31 March 2024 | 46.4 | 2.9 | 49.3 |
| Property leases | Other leases | Total | |
| £m | £m | £m | |
| 2024 | 2023 | |
| £m | £m | |
Balance at beginning of year | 31.4 | 18.4 |
Additions – business combinations | 0.7 | – |
Additions | 6.0 | 18.1 |
Modifications | – | (1.0) |
Payments made (cash flows from financing activities) | (4.8) | (5.6) |
Interest charge | 0.8 | 0.5 |
Effect of movements in foreign exchange rates | (0.7) | 1.0 |
33.4 | 31.4 | |
Amounts falling due after more than one year | 28.6 | 26.2 |
Amounts falling due in less than one year | 4.8 | 5.2 |
| 2024 | 2023 | |
| £m | £m | |
Interest on lease liabilities | (0.8) | (0.5) |
Amortisation of right-of-use assets | (5.0) | (4.6) |
| 2024 | 2023 | |
| £m | £m | |
Raw materials and consumables | 59.0 | 39.8 |
Work in progress | 27.3 | 23.5 |
Finished goods | 22.1 | 18.1 |
108.4 | 81.4 |
| 2024 | 2023 as restated | |
| £m | £m | |
Trade receivables | 88.5 | 91.3 |
Less provision for impairment of receivables | (3.6) | (3.5) |
Net trade receivables | 84.9 | 87.8 |
Accrued income | 11.7 | 9.4 |
Prepayments | 9.9 | 6.6 |
Other receivables | 8.2 | 9.4 |
114.7 | 113.2 |
| 2024 | 2023 | |
| £m | 3m | |
UK | 11.6 | 17.5 |
China | 16.1 | 16.2 |
Japan | 15.5 | 15.8 |
USA | 24.3 | 29.8 |
Germany | 6.4 | 7.4 |
Rest of Europe | 16.1 | 10.6 |
Rest of Asia | 10.4 | 6.3 |
Rest of World | 4.4 | 3.0 |
104.8 | 106.6 |
| 2024 | 2023 | |
| £m | £m | |
Current (not overdue) | 54.7 | 63.1 |
Less than 31 days overdue | 20.5 | 18.8 |
More than 30 but less than 91 days overdue | 15.2 | 10.8 |
More than 90 days overdue | 14.4 | 13.9 |
104.8 | 106.6 |
| 2024 | 2023 | |
| £m | £m | |
Balance at start of year | 3.5 | 3.6 |
Increase/(decrease) in loss allowance recognised in the Consolidated Statement of Income during the year | 0.1 | (0.1) |
Balance at end of year | 3.6 | 3.5 |
2024 | 2023 as restated | |||||
| Contract | Contract | |||||
asset | Contract liability | asset | Contract liability | |||
| Accrued | Customer | Deferred | Accrued | Customer | Deferred | |
| income | deposits | income | income | deposits | income | |
| £m | £m | £m | £m | £m | £m | |
Balance at 1 April | 9.4 | (52.1) | (21.3) | 4.2 | (41.3) | (21.2) |
Acquired balances | – | (0.4) | (0.7) | – | – | – |
| Transfers in the period from contract assets | ||||||
to trade receivables | (9.4) | – | – | (4.2) | – | – |
Amounts included in contract liabilities that were recognised as revenue during the period | – | 48.5 | 21.3 | – | 38.6 | 21.2 |
| Excess of revenue recognised over cash (or rights | ||||||
to cash) being recognised during the period | 11.7 | – | – | 9.4 | – | – |
Cash received in advance of performance and not recognised as revenue during the period | – | (54.4) | (22.2) | – | (49.4) | (21.3) |
Balance at 31 March | 11.7 | (58.4) | (22.9) | 9.4 | (52.1) | (21.3) |
| 2024 | 2023 | |
| £m | £m | |
Cash balances | 97.8 | 112.7 |
Bank overdrafts (Note 19) | (12.3) | (11.2) |
Cash and cash equivalents in the Consolidated Statement of Cash Flows | 85.5 | 101.5 |
| 2024 | 2023 | |
| £m | £m | |
| Current | ||
Bank loans at First Light Imaging | 0.4 | – |
Covid-19 loan at WITec | 0.4 | 0.4 |
Bank overdrafts | 12.3 | 11.2 |
At the end of the year | 13.1 | 11.6 |
| 2024 | 2023 | |
| £m | £m | |
| Non-current | ||
Bank loans at First Light Imaging | 0.4 | – |
Covid-19 loan at WITec | 0.5 | 0.9 |
At the end of the year | 0.9 | 0.9 |
| 2024 | 2023 | |
| £m | £m | |
Balance at the beginning of the year | 12.5 | 10.5 |
Increase in borrowings (from acquisition of First Light Imaging) | 2.2 | – |
Repayment of borrowings (cash flow from financing activities) | (1.8) | (0.5) |
Increase/(decrease) in bank overdrafts | 1.1 | 2.5 |
Interest charged | 0.9 | 0.7 |
Interest paid | (0.9) | (0.7) |
At the end of the year | 14.0 | 12.5 |
| 2024 | 2023 | |
| £m | £m | |
Trade payables | 32.6 | 30.3 |
Customer deposits | 58.4 | 52.1 |
Social security and other taxes | 6.3 | 6.1 |
Accrued expenses | 39.3 | 44.9 |
Deferred income | 22.9 | 21.3 |
Other payables | 6.7 | 4.7 |
166.2 | 159.4 |
| Warranties | IP-related claims | Other | Total | |
| £m | £m | £m | £m | |
Balance as at 1 April 2023 | 3.6 | 0.6 | 3.4 | 7.6 |
Provisions made during the year | 3.5 | – | 1.3 | 4.8 |
Provisions used during the year | (1.8) | – | (1.3) | (3.1) |
Provisions released during the year | (2.1) | – | (0.7) | (2.8) |
Exchange differences | – | – | (0.1) | (0.1) |
Balance as at 31 March 2024 | 3.2 | 0.6 | 2.6 | 6.4 |
Amounts falling due before one year | 3.2 | 0.6 | 2.6 | 6.4 |
Amounts falling due after more than one year | – | – | – | – |
2024 | 2023 as restated | ||||
| Carrying | Carrying | ||||
| amount | Fair value | amount | Fair value | ||
| £m | £m | £m | £m | £m | |
| Financial assets measured at fair value | |||||
| Derivative financial assets: | |||||
– Foreign currency contracts | 2 | 2.5 | 2.5 | 2.0 | 2.0 |
| Financial assets measured at amortised cost | |||||
Long-term receivables | 1.3 | 0.5 | |||
Trade receivables | 84.9 | 87.8 | |||
Other receivables and accrued income | 15.1 | 13.0 | |||
Cash and cash equivalents | 97. 8 | 112.7 | |||
| Financial liabilities measured at fair value | |||||
| Derivative financial liabilities: | |||||
– Foreign currency contracts | 2 | (0.1) | (0.1) | (1.2) | (1.2) |
| Financial liabilities measured at amortised cost | |||||
Trade and other payables | (78.6) | (79.9) | |||
Bank overdrafts | (12.3) | (11.2) | |||
Borrowings | (1.7) | (1.3) | |||
Lease payables | (33.4) | (31.4) |
| 2024 | 2023 as restated | |
| £m | £m | |
Long-term receivables | 1.3 | 0.5 |
Trade receivables | 84.9 | 87.8 |
Other receivables and accrued income | 15.1 | 13.0 |
Cash and cash equivalents | 97. 8 | 112.7 |
Derivative financial instruments | 2.5 | 2.0 |
201.6 | 216.0 |
| Carrying | Contractual | Due within | Due one to | Due more than | |
| amount | cash flows | one year | five years | five years | |
| 2024 | £m | £m | £m | £m | £m |
Foreign exchange contracts | (0.1) | 0.1 | 0.1 | – | – |
Trade and other payables | (78.6) | 78.6 | 78.6 | – | – |
Bank overdrafts | (12.3) | 12.3 | 12.3 | – | – |
Borrowings | (1.7) | 1.7 | 1.2 | 0.5 | – |
Lease payables | (33.4) | 36.8 | 5.3 | 17.3 | 14.2 |
(126.1) | 129.5 | 97.5 | 17.8 | 14.2 |
| Carrying | Contractual | Due within | Due one to | Due more than | |
| amount | cash flows | one year | five years | five years | |
| 2023 | £m | £m | £m | £m | £m |
Foreign exchange contracts | (1.2) | 1.2 | 1.2 | – | – |
Trade and other payables | (79.9) | 79.9 | 79.9 | – | – |
Bank overdrafts | (11.2) | 11.2 | 11.2 | – | – |
Borrowings | (1.3) | 1.3 | 0.4 | 0.9 | – |
Lease payables | (31.4) | 31.4 | 4.5 | 13.8 | 13.0 |
(125.0) | 125.0 | 97. 2 | 14.7 | 13.0 |
| Carrying amount | Carrying amount | |
| 2024 | 2023 | |
| £m | £m | |
| Variable rate instruments | ||
Cash and cash equivalents | 97. 8 | 112.7 |
Bank overdrafts | (12.3) | (11.2) |
| Fixed rate instruments | ||
Financial assets | – | – |
Bank loans | (1.7) | (1.3) |
| 2024 | |||
| 1% increase in | 10% weakening | 10% strengthening | |
| interest rates | in Sterling | in Sterling | |
| 2023 | £m | £m | £m |
Impact on adjusted profit (Note 2) | 0.9 | (10.2) | 10.2 |
Impact on reported profit | 0.9 | ( 7. 5) | 7.5 |
Impact on equity | 0.8 | (6.1) | 6.1 |
| 2024 | 2023 | |
| £m | £m | |
Present value of funded obligations | 223.6 | 225.1 |
Fair value of plan assets | (239.7) | (251.5) |
Recognised asset for defined benefit obligations | (16.1) | (26.4) |
| 2024 | 2023 | |
| £m | £m | |
Benefit obligation at the beginning of the year | 225.1 | 300.0 |
Past service cost | 0.4 | – |
Interest on defined benefit obligation | 10.5 | 8.2 |
Benefits paid | (11.0) | (12.3) |
Remeasurement (gain)/loss on obligation | (1.4) | (70.8) |
Benefit obligation at the end of the year | 223.6 | 225.1 |
| 2024 | 2023 | |
| £m | £m | |
Fair value of plan assets at the beginning of the year | 251.5 | 351.7 |
Interest on plan assets | 12.0 | 9.8 |
Contributions by employer | 8.5 | 12.2 |
Benefits paid | (11.0) | (12.3) |
Administrative expenses | (0.5) | (0.5) |
Actual return on assets excluding interest income | (20.8) | (109.4) |
Fair value of plan assets at the end of the year | 239.7 | 251.5 |
| 2024 | 2023 | |
| £m | £m | |
Total defined benefit income | (1.0) | (1.1) |
Contributions to defined contribution schemes | 6.5 | 6.2 |
5.5 | 5.1 |
| 2024 | 2023 | |
| £m | £m | |
Cost of sales | 2.1 | 1.7 |
Research and development | 1.6 | 1.5 |
Selling and marketing costs | 1.3 | 1.4 |
Administration and shared services | 2.0 | 2.1 |
Financial income | (1.5) | (1.6) |
5.5 | 5.1 |
| Discount rate | Inflation rate | Life expectancy | ||
| 2024 | (-0.1% p.a.) | (+0.1% p.a.) | (+one year) | |
| £m | £m | £m | £m | |
Present value of funded obligations | 223.6 | 226.5 | 225.9 | 231.0 |
Fair value of plan assets | (239.7) | (239.7) | (239.7) | (239.7) |
Surplus | (16.1) | (13.2) | (13.8) | (8.7) |
| 2024 | 2023 | |
| % | % | |
Discount Rate | 4.8 | 4.8 |
Rate of increase in pensions in payment (‘3LPI’) | 2.2 | 2.3 |
Rate of increase in pensions in payment (‘5LPI’) | 2.9 | 3.0 |
Rate of inflation (‘CPI’) | 2.3 | 2.4 |
Rate of inflation (‘RPI’) | 3.0 | 3.2 |
| 91% of S2PA tables | 97% of S2PA tables | |
| (93% for females) future | (99% for females) future | |
| improvement in line with CMI | improvement in line with CMI | |
| Mortality – pre and post-retirement | 2022 with 1.25% long-term trend | 2021 with 1.25% long-term trend |
| 2024 | 2023 | |
| years | years | |
Pre-retirement – males | 23.2 | 23.2 |
Pre-retirement – females | 25.3 | 25.3 |
Post-retirement – males | 21.8 | 21.9 |
Post-retirement – females | 23.8 | 23.8 |
| 2024 | 2023 | |
| £m | £m | |
Equities | 7.5 | 62.9 |
Corporate and Emerging Market Bonds | 22.9 | 22.1 |
Gilts | 174.3 | 113.5 |
Property | – | 5.4 |
Insurance-linked funds | 5.8 | 12.2 |
Credit and global loan funds | 0.1 | 0.1 |
Hedge funds | 24.3 | 25.5 |
Cash | 4.8 | 9.8 |
239.7 | 251.5 |
| 2024 | 2023 | |
| Number | Number | |
| of shares | of shares | |
At the beginning of the year | 57,712,508 | 57,654,455 |
Issued for cash | 201,284 | 58,053 |
At the end of the year | 57,913,792 | 57,712,508 |
2024 | 2023 | |||
Number of shares | £m | Number of shares | £m | |
| Allotted, called up and fully paid | ||||
Ordinary shares of 5 pence each | 57,913,792 | 2.9 | 57,712,508 | 2.9 |
| LTIP: | ||||||||
| LTIP CEO | LTIP CEO | Conditional | ||||||
| LTIP: CEO | buy-out 2021 | buy-out 2022 | LTIP CFO | LTIP: Options | Shares | |||
| November | November | November | September | September | September | PSP: MTIP | PSP June | |
| 2023 | 2023 | 2023 | 2023 | 2023 | 2023 | June 2022 | 2022 | |
Weighted average fair value of options granted | £16.99 | £11.04 | £13.38 | £18.19 | £19.09 | £21.16 | £18.86 | £18.86 |
Share price at grant date | £20.55 | £20.55 | £20.55 | £21.75 | £21.75 | £21.75 | £19.40 | £15.80 |
Exercise price | £0.05 | £0.05 | £0.05 | £0.05 | £0.05 | £0.05 | £0.05 | £0.05 |
Expected volatility | 41.3% | 31.5% | 30.9% | 40.5% | 40.5% | n/a | 47. 3% | 47.3% |
Expected option life | 3 years | 0.5 years | 1.5 years | 3 years | 3 years | 3 years | 3 years | 3 years |
Expected dividend yield | – | – | – | – | 0.9% | 0.9% | 0.9% | 0.9% |
Risk-free interest rate | 4.4% | 5.3% | 4.9% | 4.4% | 4.4% | n/a | 2.1% | 2.1% |
| Executive Share | Performance | Long-Term | ||||
| Option Scheme | Share Plan | Incentive Plan | ||||
| Weighted | Weighted | Weighted | ||||
| Number | average | Number | average | Number | average | |
| of shares | exercise price | of shares | exercise price | of shares | exercise price | |
Outstanding at 1 April 2022 | 137,278 | £8.83 | 741,768 | £0.05 | – | – |
Granted | – | – | 163,687 | £0.05 | – | – |
Forfeited | – | – | (4,989) | £0.05 | – | – |
Exercised | (8,163) | £8.80 | (52,260) | £0.05 | – | – |
Lapsed | (3,446) | £9.44 | (19,830) | £0.05 | – | – |
Outstanding at 31 March 2023 | 125,669 | £8.8 | £0.05 | – | – | |
Granted | – | – | – | – | 216,207 | £0.05 |
Forfeited | – | – | (25,533) | £0.05 | – | – |
Exercised | (18,623) | £8.93 | (180,018) | £0.05 | – | – |
Lapsed | (8,317) | £10.28 | (318) | £0.05 | (15,635) | £0.05 |
Outstanding at 31 March 2024 | 98,729 | £8.68 | 622,507 | £0.05 | 200,572 | £0.05 |
Exercisable at 31 March 2024 | 98,729 | £8.68 | 362,419 | £0.05 | 12,237 | £0.05 |
Exercisable at 31 March 2023 | 125,669 | £8.82 | 402,140 | £0.05 | – | – |
| Payables and | Customer | ||||
| Inventories | Receivables | provisions | Deposits | Total | |
| £m | £m | £m | £m | £m | |
As at 1 April 2022 | 65.3 | 95.8 | (107. 5) | (41.3) | 12.3 |
Working capital movement | 15.6 | 19.6 | (16.9) | (9.2) | 9.1 |
WITec-related flows | – | – | 5.3 | – | 5.3 |
Exchange differences | 0.5 | 0.3 | – | (1.6) | (0.8) |
FV movement on financial derivatives | – | – | 3.0 | – | 3.0 |
As at 31 March 2023 and 1 April 2023 | 81.4 | 115.7 | (116.1) | (52.1) | 28.9 |
Working capital movement | 26.3 | 2.7 | 2.8 | (7.1) | 24.7 |
First Light Imaging-related flows | 1.9 | 2.9 | (5.0) | (0.4) | (0.6) |
Exchange differences | (1.2) | (2.8) | 4.7 | 1.2 | 1.9 |
FV movement on financial derivatives | – | – | (0.7) | – | (0.7) |
As at 31 March 2024 | 108.4 | 118.5 | (114.3) | (58.4) | 54.2 |
| 2024 | 2023 | |
| £m | £m | |
Short-term employee benefits | 4.8 | 4.2 |
Post-employment benefits | 0.2 | 0.1 |
Share-based payment charges | 2.6 | 1.8 |
Total | 7.6 | 6.1 |